Organon Investor Relations Material
Latest events
Q1 2025
Organon
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Organon & Co
Access all reports
Segment Data
Access more data
Revenue by
Geography
Europe and Canada
U.S.
Asia Pacific and Japan
China
Other
Expenses by
Financials
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. The company operates under the Organon & Co. Pharmaceuticals and Organon brands. Its products include hormone contraceptives; biosimilars; women's health products consisting of fertility, menopause, contraception, osteoporosis and gynecological cancer; and treatments for psychiatric and neurological disorders comprising schizophrenia, bipolar mania disorder and depression. The company also offers food animal health products, including pain relief for horses, cattle and sheep; and anti-infectives for poultry.
Key slides for Organon & Co
Q4 2024
Organon & Co
Q3 2024
Organon & Co
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
OGN
Country
🇺🇸 United States